New Los Angeles earthquake on same fault could be deadlier than ‘Big One’

http://www.theguardian.com/world/2014/mar/30/los-angeles-earthquake-fault-deadlier-than-big-one

New Los Angeles earthquake on same fault could be deadlier than ‘Big One’

• Seismologists warn of danger of Puente Hills thrust fault
• 4.8 earthquake hits Yellowstone National Park

Advertisements

Special Report!! Americas Homeless Epidemic

America, please view below pictures attached, compliments of  “Positive Minded People” of Los Angeles, California.

The groups latest venture to help the “Homeless people of Downtown Los Angeles, they organized “Skid Row”, by which 20 group members gave out over $6000 worth of donated cash and supplies to over 300 homeless citizens. The standing lines in the pictures is a horrific sight to see! How can this be in America?  Does anyone not care in America? Does the American Government and Agencies not see this growing epidemic in America?

 Although, I couldn’t be there to participate in “Skid Row” I give a huge ‘THANKS’ to a great group of positive minded people, I happen to be part of! They are making a difference in America, by first realizing there is a homeless problem In America, 2nd by initiating an action plan to help the many homeless citizens of California, 3rd by sharing their story with America, for all to see United States has a major homeless problem!

Is anyone not noticing this is occurring throughout America, or do you choose to turn a blind-eye? Please realize homelessness is not racially specific it’s happening to many ethnicities in the United States. The most disturbing fact commented; by the Founder “Bennie Mayberry,” was about a little 10yr. old boy who ran up to him and “asked him for a blanket to keep him from getting cold at night so he won’t shiver!” Why in the world is there a 10yr. old little boy homeless in America, this is very sad and hurtful. Why are American children living on the street? Why are children suffering in America?

As the founder of CABIRI, this is the exact reasoning behind why I started my online Social Media business, to help save lives in America, by reporting all news pertaining to anyone, no matter who in America or the World, whom are killing and impacting human lives! I can not sit back and watch while American people and small children are suffering, all due to many other human beings in America and around the world who care nothing about people, just how “Fat their pockets can get!” Or as for the corporations and businesses, How much they can increase their bottom lines of revenue or their investments, not taking into consideration the impact of their private sneaky choices, impacts millions of human lives. 

This should not be, these decision makers of America and around the world are human beings, just like the rest of us in the world! Do they have the right to control and impact millions of lives, just because they have more money in their pockets! Are these leaders considered, ‘Supreme Human Beings’, with power, all due to the lining in their pockets, stocks, investments or inheritance? Which is mostly by the hands of excessive corruption and greed, per the current series of events currently occurring and impacting American citizens!

Is taking over the world become an obsession with many top leaders of power, who will not stop at anything to get to that level? Which means killing and impacting American life’s, and many other world citizens as they see fit, to gain what they need to accomplish their hidden agenda worldly goals for a massive world take over!   

 America, please view pictures below and “Ask Yourselves,” should this be in America? Ask, the many organizations who are supposed to be helping the homeless people in their State, City or Town, what are they doing to help the homeless? Ask the U.S. Government to start stepping up to help it’s own suffering American citizens of the United States! Many homeless people have paid taxes to their country, so why aren’t they being helped? There is no jobs in America many citizens are unemployed!

What are they supposed to do? How are they supposed to start their lives over from scratch with no help, and feed and provide for their family and most importantly their children? A recent poll showed millions of American citizens are now on Government food assistance, which is being cut, which impacts more lives. Please realize death’s in America will start increasing even more if nothing is done soon, homelessness deteriorates the health of millions of citizens! 

America start asking questions and taking action, and continue to support the “California group “Positive Minded People” and CABIRI, Were on the ground and the internet, stepping up taking action to save millions of lives in America! Homelessness is growing by the numbers daily, many reports are coming out all throughout America proving the growing epidemic, please take notice, and if you can help or assist in anyway please step up and do what you can for those in need, before America is hit with a widespread “Great Depression, impacting all American families, including yours!”

“Stand Up help save America and American lives, before the bottom drops out, Even Worse!”

See attached “Skid Row” for the Homeless Pictures Taken 03/29/2014 – Compliments of “Positive-Minded People” 

Image

ImageImageImageImage

ImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImageImage

CABIRI,

Web Content Freelance Research Writer

What a joke suspended on criminal charges with pay! More Corruption in America.

http://www.theguardian.com/world/2014/mar/28/three-democratic-california-state-senators-suspended-criminal-cases

Three Democratic California state senators suspended over criminal cases

• Senators Calderon, Yee and Wright keep full salaries
• Republican Joel Anderson is lone vote against suspension

URGENT MESSAGE! Big Pharma Discriminating & Sterilizing WOMEN – EUGENICS

Int’l Big Pharma” Sterilizing & Discriminating Against American Women

“ALSO VIEW THE MULTIPLE “HAND ME DOWN MEGA-MERGER DRUGS”  – 

American women, pharmaceutical “Eugenics Theory” tactics harming, sterilizing and killing millions of American women. Please ask yourselves how can a pharmaceutical company who discriminates against women, truly care about womens reproductive health? You’ll view below, contradictory occurrences.

 

American women please view below information for your personal protection! Also please do your own personal due diligence before taking drugs prescribed. This is for your health, safety and well-being please try to utilize home remedies or natural health products, like grandma or your mother taught you!

 

http://www.lawyersandsettlements.com/lawsuit/drospirenone-side-effects-lawsuits.html#.UzOpO_ldXww

 

The combination of contraceptive drugs Drospirenone and ethinyl estradiol has been associated with a number of Drospirenone side effects. Bayer, the manufacturer of oral contraceptives containing theDrospirenone drug is now facing thousands of Drospirenone lawsuits. Or BERLEX, SCHERING

 

Drospirenone and Heart Attack. Drospirenone (similar to other medicines typically used as diuretics such as Spironolactone), combined with ethinyl estradiol, has shown an increase in the blood’s potassium levels. This increase can lead to hyperkalemia, which can result in cardiac arrest. Hyperkalemia often has no symptoms, and is often detected after serious heart conditions have already occurred. 

Drospirenone and Venous Thromboembolism (VTE). Drospirenone has also been associated with venous thromboembolism (VTE)—blood clots that form within a vein. A number of studies, most recently published in the BMJ(October 2011), suggest that women on these pills (listed above) containing one of the newer types of progestogen hormone (drospirenone, desogestrel or gestodene) have double the risk of VTE than women on pills containing an older progestogen (levonorgestrel).

 

Drospirenone and Deep Vein Thrombosis (DVT).Drospirenone has also been linked to deep vein thrombosis (DVT), which is a blood clot that forms in a deep vein, and pulmonary embolism—blood clots in the lungs.

New research published in the Canadian Medical Association Journal (November, 2011) involving about 330,000 women in Israel found that women taking birth-control pills containing the drospirenone were as much as 65 per cent more likely to develop venous thromboembolism than women taking older generations

of the pill Drospirenone and Gallbladder disease.It is also associated with gallbladder disease, particularly in young women.

 

 

http://www.lawyersandsettlements.com/articles/yasmin-side-effects-yaz-blood/FDA-drospirenone-birthcontrol-labeling-change-17604.html#.UzOrAfldXww

Washington, DC: The Food and Drug Administration (FDA) announced today that it is revising the labels fordrospirenone-containingbirth control pills, warning of the higher associated risk for blot clots.

The change results from a newly completed review by the FDA of recent observational (epidemiologic) studies regarding the risk of blood clots in women taking drospirenone-containing birth control pills. Based on this review, the FDA has concluded that drospirenone-containing birth control pills may be associated with a higher risk for blood clots than other progestin-containing pills.

Drospirenone is a synthetic version of the female hormone, progesterone, also referred to as a progestin. FDA is adding information about the studies to the labels of drospirenone-containing birth control pills.

Drospirenone lawsuits against Bayer—both involving side effects and deceptive marketing of Yaz and Yasmin–allege that the drug company:

  • Underplayed the risks associated with the products and overstated their approved uses in an effort to mislead users of Yaz and Yasmin into believing that the drugs were safe.

  • Failed to properly research the medication.

  • Failed to recall the drug after post-marketing reports demonstrated that the risk of potentially life-threatening side effects of Yasmin and Yaz outweighed potential benefits that could be achieved via other available oral contraceptives.

 

http://www.lawyersandsettlements.com/lawsuit/ams-transvaginal-mesh.html#.UzOsk_ldXww

AMS Transvaginal Mesh injury includes debilitating and potentially life-long complications, which has led to AMS legal complaints. Many AMS transvaginal mesh lawsuits have been filed by women who were implanted with AMS transvaginal mesh, claiming the AMS mesh is defective. American Medical Systems (AMS), based in Minnesota, is a major manufacturer of transvaginal meshmedical devices, which are support systems designed to correct pelvic organ prolapse, (POP) and stress urinary incontinence (SUI).

Johnson & Johnson is the global leader in prolapse mesh, followed by American Medical Systems, Boston Scientific, and Bard. As more women are implanted with TVM, complaints are on the rise: Between 2008 and 2010, the FDA received 1,503 reports of injuries or malfunction, a fivefold increase from 2005 to 2007.

In 2010, about 300,000 women in the US had pelvic organ prolapse (POP) surgeries, including more than 70,000 who received vaginal meshes. Approximately185,000 women underwent procedures in which mesh was implanted vaginally to treat stress urinary incontinence (SUI).

 

The FDA has received a number of adverse reports regarding AMS transvaginal mesh. These reports have resulted in a number of lawsuits filed against the company by women who may have been implanted with the following AMS mesh:

  • AMS Apogee Vault Suspension System

  • AMS Elevate Prolapse Repair System

  • AMS Monarc Sling System

  • AMS Perigee System

  • AMS Sparc Sling System

$54.5M Settlement Proposed for Some Transvaginal Mesh Lawsuits Endo Health Solutions Inc, which acquired American Medical Systems Inc., (AMS), the maker of the vaginal-mesh devices, which include the Perigee, Apogee and Elevate implants, said in a statement that is set to resolve an undisclosed number of the vaginal mesh personal injury lawsuits. However, AMs is facing over 5,000 such lawsuits, which have been consolidated: the first lawsuit set to go to court in December 2013.

http://www.bigclassaction.com/settlement/54-5m-settlement-proposed-some-transvaginal-mesh.php

New Mirena Lawsuit Claims Woman Sustained Permanent Injuries During “Unethical” Clinical Trial Testing Off-Label Use of Mirena IUD

Yahoo Finance·NEW YORK, March 26, 2014 /PRNewswire/ — A new Mirena lawsuit(http://www.themirenalawsuitcenter.com) has been filed against the Washington University School…

            TransWorldNews·

                      Injury Lawyer News· MirenaLawsuit– Litigation & Claims Related to the IUD

                      http://www.drugrisk.com/mirena/lawsuit

                      Mirena Lawsuit & Claim Information. Since Mirena IUDs were released in 2000, they have been used by more than 10 million women in the United States.

                      Beyaz Birth ControlThe US Food and Drug Administration (FDA) has issued a warning that women using birth control similar to Beyaz birth controlcould be at increased risk of drospirenone side effects. According to the FDA and researchers, drugs such as Beyaz birth control, which contain drospirenone are associated with an increased risk of blood clots. The FDA is now investigating potential Beyaz side effectsand other drospirenone reactions. Although lawsuits have been filed against other birth control makers, so far no Beyaz lawsuitshave been filed.

                      On September 26, 2011, the FDA issued a warning that the use of birth control medications that contain drospirenonecould potentially be linked to an increased risk of blood clots. The announcement came after the FDA completed a review of two studies from 2011 that evaluated the risk of blood clots in women who use medications that contain drospirenone. Furthermore, the FDA has funded a study that evaluates the risk of blood clots in women who use hormonal birth control products. Preliminary results of that study suggest that women who take a birth control pill containing drospirenone has approximately 1.5 times the risk of blood clots of women who use other hormonal contraceptives.
                      http://www.lawyersandsettlements.com/lawsuit/beyaz-side-effects-lawsuit.html#.UzOvxPldXww

                      Beyaz side effectsare similar to those of Yasmin and Yaz, and even though some lawsuits name all three birth control pills, Bayer’s Annual Report 2013 does not mention Beyaz in its Legal Risks Section. The Annual Report discusses other Beyaz lawsuit risks, but not those alleging side effects from Beyaz birth control

                      http://www.lawyersandsettlements.com/lawsuit/nuvaring-blood-clot-death-removed.html#.UzOx2PldXww

                      NuvaRing lawsuitshave been filed alleging women suffered serious side effects as a result of using the NuvaRing birth control. Among the reported side effects is an increased risk of NuvaRing strokeand NuvaRing blood clots, some of which have allegedly resulted in the deaths of young women.

                      NuvaRing Birth Control – Same as the Mirena-Iud – NuvaRing is a birth control product that is placed near the cervix and releases a dose of synthetic hormones—etongestrel (a progestin) and ethinyl estradiol (estrogen)—over a 21-day period. The vaginal ring is taken out after the 3-week period and then left out for one week to allow for menstruation. Following that week, a new ring is inserted.

                      NuvaRing works by suppressing ovulation and also by thickening cervical mucus to help ensure fertilization cannot occur. NuvaRing was approved by the US Food and Drug Administration (FDA) for use in 2001.

                      NuvaRing, along with other third- and fourth-generation contraceptives, has been linked to an increased risk of blood clots. Two studies, published in 2009 in the British Medical Journal, found that third- and fourth-generation contraceptives were associated with almost twice the risk of a blood clot, compared with second-generation contraceptives. If a blood clot comes loose and travels to the patient’s brain, this can cause a stroke, which can have serious and fatal repercussions for the patient. Patients who survive their stroke may wind up with lifelong injuries, including paralysis.

                      Merck Settles Nuvaring Litigation Commenced by Attorney Jason T. Brown for 100 Million Dollarshttp://www.lawyersandsettlements.com/articles/nuvaring-blood-clot-death-removed/nuvaring-lawsuit-blood-clots-side-10-19506.html#.UzOzPPldXww

                      NuvaRing: Lawsuits Allege Merck Downplayed Risks

                      http://www.lawyersandsettlements.com/articles/nuvaring-blood-clot-death-removed/nuvaring-lawsuit-blood-clots-side-8-17967.html#.UzOzofldXww

                      Avaulta – Bard Avaulta Mesh System, Avaulta Lawsuit

                      Serious complications have been associated with transvaginal surgical mesh , which is used to treat pelvic organ prolapse (POP) and Stress Urinary Incontinence (SUI). Lawsuits have been filed against C.R. Bard, the manufacturer of Bard Avaulta mesh , alleging the Bard Avaulta System is defective. Avaulta Mesh An increasing nu…

                      An increasing number of complaints have been reported to the FDA against the makers of transvaginal mesh(TVM) medical devices. Bard Avaulta TVM problems range from pain during sex to erosion of vaginal tissue and infection to even death.

                      Pelvic Organ Prolapse (POP)

                      Bard Avaulta transvaginal mesh (TVM) is used to treat pelvic organ prolapse (POP), which occurs when organs, including the uterus or bowel, drop against the wall of the vagina. In some cases, synthetic vaginal mesh such as Avaulta is implanted to support the muscle. In other cases, surgeons stitch the connective tissue in the vaginal wall back together. Bard surgical mesh is also used to treat Stress Urinary Incontinence (SUI).

                      http://www.lawyersandsettlements.com/lawsuit/bard-avaulta-mesh-implant-system.html#.UzO1EPldXww

                       

                      Currently product liability lawsuits are being filed against a number of transvaginal mesh manufacturers, including Bard, claiming that the vaginal slings were negligently designed, causing pain and other complications.

                      Lawsuits filed against C.R. Bard, the maker of Bard Avaulta Anterior and Posterior Biosynthetic Support System, also known as Bard Avaulta Mesh or Bard Avaulta System, allege serious Avaulta meshcomplications

                      A number of pelvic organ prolapse (POP) patients with the Bard Avualta vaginal mesh claim that defects in the design of the synthetic mesh caused them to suffer severe injuries and complications after surgery. Further, lawsuits allege that Bard knew or should have known about the dangers and risk of problems with its synthetic mesh but the company continued to market and promote the product as a safe and effective treatment for POP, while minimizing the risks of a Bard Avaulta procedure. Lawsuits claim that Bard failed to adequately research the product and establish that it provides both long term and short term efficacy.

                      Bard, based in Georgia, manufactures, distributes, and markets numerous medical devices. Brand names of Bard’s transvaginal mesh patches include: Avaulta Plus™ BioSynthetic Support System; Avaulta Solo™ Synthetic Support System; Faslata® Allograft;Pelvicol® Tissue; PelviSoft® Biomesh’;Pelvitex™ Polypropylene Mesh


                      The FDA has received over a thousand reports of
                      Bard Avaultacomplications associated with surgical mesh since 2005. Complications most frequently involve erosion through the vaginal epithelium (in 2010, more than 75,000 women had vaginal mesh surgery to repair POP, at least 10 percent of whom suffered mesh erosion that required surgery to remove the mesh within 12 months); extrusion; infection; hardening of the mesh; chronic pain, and damage to surrounding organs.

                      Further problems reportedly include bowel, bladder and blood vessel perforation during insertion. In some cases, patients have undergone follow-up surgery to correct these problems. Because of its design, which allows tissue infiltration, the Bard Avualta mesh makes removal of the mesh very dangerous and potentially life-threatening. Other patients underwent IV therapy, blood transfusions and drainage of their hematomas or abscesses.

                      http://www.lawyersandsettlements.com/lawsuit/bard-avaulta-mesh-implant-system.html#.UzO1EPldXww

                      Bayer Female Employee Discrimination Class Action Amended to Include Sales Representatives-

                      http://www.bigclassaction.com/lawsuit/bayer-employee-discrimination-class-action-sales.phpNewark, NJ:Just days after the one year anniversary of winning a $250 million verdict for female sales representatives at Novartis Pharmaceuticals Corporation, a nearly identical discriminationclass action has been filed on behalf of female sales representatives at Bayer HealthCare Pharmaceuticals.According to the amended complaint, there is an entirely new class of plaintiffs and an additional Bayer HealthCare Division now added to the case. The Amended Complaint adds two new Class Representatives — a sales representative and an employee at Consumer Care — to join the six Class Representatives who filed the original complaint in March of this year on behalf of themselves and a class of female managers in the United States under Title VII of the 1964 Civil Rights Act and New Jersey law on March 21, 2011 .

                      Female Sales Rep Files Discrimination Class Action Against MerckNewark, NJ: A $100 million individual and class action suit has been filed in the US District Court for New Jersey against pharmaceutical giant Merck & Co., Inc. The action, filed by Sanford Heisler LLP, was brought by Kelli Smith on behalf of all female sales representatives at Merck.

                      The lawsuit asserts that the company systematically discriminatesagainst its female and pregnant employees in assignment, promotion, advancement, and pay and retaliates against female employees in violation of Title VII of the US Civil Rights Act, the Lilly Ledbetter Fair Pay Act, the Family and Medical Leave Act and the New Jersey Law Against Discrimination.

                      “Merck is a male-dominated workplace openly hostile to the success and advancement of women,” said David Sanford, Founder and Chairman of Sanford Heisler and lead attorney on Ms. Smith’s legal team. “Its discrimination against mothers is particularly egregious because Merck’s compensation structure decreases the pay of managers whose subordinates take maternity leave.”

                      Ms. Smith’s lawsuit details a widespread pattern of employment discrimination. Merck discourages management from hiring and promoting women, attempts to force pregnant women to leave the company so their managers’ compensation will not be affected, and structures compensation so that managers and colleagues of pregnant women get paid less because they work with women who take maternity leave.http://www.bigclassaction.com/lawsuit/female-sales-rep-discrimination-class-action-merck.php

                      Melnick Sisters Reach Settlement in Eli Lily DES Lawsuit
                      Boston, MA: A potential settlement has been reached between four sisters and the drug company Eli Lily, which could end the women’s lawsuit that alleges the diethylstilbestrol (DES) they were exposed to in the womb caused them to develop breast cancer. Between 1940 and 1971, DES was commonly used to prevent miscarriage and other pregnancy compl…http://www.lawyersandsettlements.com/search.html?keywords=male+lawsuits&page=11

                      Firm Admits Birth Control Pill Mixup

                      July 02, 1998|By From Tribune News Services.

                      SAO PAULO, BRAZIL — A Germanpharmaceuticalgroup acknowledged Wednesday making mistakes in a birth control pill mixup that allegedly left at least 11 Brazilian women pregnant. The drug group, Schering AG, said it would compensate the victims.

                      Two metric tons of placebo pills may have made their way to Brazilian consumers after disappearing from either Schering’s plant or an incineration facility in January, officials said.

                      http://articles.chicagotribune.com/1998-07-02/news/9807020361_1_schering-ag-pills-brazilian

                       

                      Survey finds many NIH scientists also hired by drug firms

                      December 08, 2003By David Willman, Tribune Newspapers: Los Angeles Times.

                      BETHESDA, Md. — Subject No. 4 died at 1:44 a.m. on June 14, 1999, in the immense federal research clinic of the National Institutes of Health.

                      The cause of Jamie Ann Jackson’s death was clear: a complication from an experimental treatment for kidney inflammation using a drug made by the German company Schering AG.

                      Among the first to be notified about the 42-year-old patient’s death was Dr. Stephen Katz, the senior NIH official whose institute conducted the study.

                      “Science should be for the sake of gaining knowledge and looking for the truth,” said Dr. Curt Furberg, former head of clinical trials at the National Heart, Lung and Blood Institute. “There should be no other factors involved that can introduce bias on decision-making.”

                      http://articles.chicagotribune.com/2003-12-08/news/0312080165_1_schering-ag-nih-dr-stephen-katz

                       

                      German glass ceiling is thick, experts say (interesting) germany not women friendly!

                       

                      April 10, 2002|By Nora FitzGerald. Special to the Tribune.

                      BERLIN — More than 3,000 of the 8,000 employees at Schering AG, a German pharmaceuticals company in Berlin, are women. Not one of them has reached the management board, called the Vorstand. Nor are there any women on its advisory council.

                      The glass ceiling is secure at Schering, just as it is in almost every German company, according to middle-level female executives and social scientists.

                      “Women have to fight for lead positions,” said Reinhild Engel, an equal opportunity official at Schering. “We have to change the company culture and the social culture.

                       

                      Actavis to sell generic Yaz birth control after ruling Livlihoods

                      April 16, 2013|Reuters

                      WASHINGTON (Reuters) – Pharmaceutical company Actavis Inc said on Tuesday that it would once again sell a generic version of Bayer AG’s Yaz after an appeals court ruled that Bayer’s patent for the oral contraceptive was invalid.

                      The U.S. Court of Appeals for the Federal Circuit ruled on Tuesday that a U.S. District Court in Nevada erred last March in finding the patent to be valid. It reversed the ruling.

                      Yaz is a reformulated version of Yasmin and remains one of the top-selling contraceptives in the United States. Actavis said that U.S. sales of Yaz, both branded and generic, were about $347 million annually.

                      Bayer’s Yasmin brand has been controversial. In 2012, Bayer agreed to pay a combined $400 million to settle almost one third of about 6,000 legal claims in the United States that Yasmin caused blood clots.

                      In April 2012, the FDA added information to the labels on Bayer’s Yaz and Yasmin, as well as others, to show they may raise the risk of blood clots.

                      All common birth control pills increase the chances of potentially fatal blood clots, but the FDA said the danger may be greater for more recent pills that contain the synthetic hormone drospirenone.

                      The cases at the Federal Circuit are: Bayer Healthcare Pharmaceuticals, Inc. v. Watson Pharmaceuticals Inc. and Sandoz Inc. (Case Nos. are 2012-1397, -1398, -1400) and Bayer Schering Pharma AG v. Watson Pharma and Lupin, Ltd. (Case No. 2012-1424.)

                      (Reporting by Diane Bartz in Washington and Bill Berkrot in New York; Editing by Andrew Hay and Leslie Adler)

                      http://articles.chicagotribune.com/2013-04-16/lifestyle/sns-rt-us-bayer-yasmin-patentbre93f13y-20130416_1_yaz-lupin-ltd-yasmin

                       

                      Baby Boom Forces Brazil To Confront Fake Medicines

                      July 14, 1998|By Laurie Goering, Tribune Foreign Correspondent.

                      RIO DE JANEIRO — After undergoing uterine surgery, Valquiria Carvalho had strict orders from her doctor not to become pregnant. He recommended birth control pills and prescribed Brazil’s most popular brand, Microvlar. 

                      Brazil is fighting back. This month the country stepped up an unprecedented crackdown on fraudulent medication after one of the highest-profile scams in years, the release of the batch of placebo birth-control pills as the real thing.

                      In January and February the Schering company of Brazil, a subsidiary of German pharmaceutical giant Schering AG, tested a new packaging machine on its Microvlar production line.

                      Flour substituted in the tests for the drug, one of Brazil’s most popular, with 1.8 million users annually. At the end of the testing, more than a ton of packaged pills and other leftovers from the testing process were shipped to an incinerator to be destroyed.

                      Feb 29, 2008, 9:07am EST

                      Bayer ’07 profit rises

                      Bayer AG profit nearly tripled in 2007 on strong sales of pharmaceuticals, the company said Thursday.

                      The rise was attributed in part to the purchase in 2006 of German rival Schering AG, which gained Bayer the Betaseron multiple sclerosis treatment.

                      Profit rose to $7.1 billion in 2007, up from $2.6 billion in 2006. Earnings per share rose from $3.36 to $8.86. Company revenue was up 12 percent to $49 billion.

                      However, fourth-quarter net income dropped 78 percent, year-over-year to $101.2 million, due to one-time expenses, including the integration of Schering.

                      Bayer has its North American headquarters in the Pittsburgh suburb of Robinson Township, where it employs about 1,500.

                      http://www.bizjournals.com/pittsburgh/stories/2008/02/25/daily44.html

                      Sep 24, 2007, 8:55am PDT UPDATED: Sep 24, 2007, 1:31pm PDT

                      Sonus breast cancer drug fails key trial

                      Sonus Pharmaceuticals Inc. said that its Tocosol Paclitaxel breast cancer drug failed in a phase 3 pivotal trial and as a result, the drug won’t be submitted to the Food and Drug Administration for approval.

                      The news was crushing to the Bothell biotech (NASDAQ: SNUS), which raised $17.8 million in August 2005 to pay for the drug trial. Shares in Sonus plummeted nearly 84 percent in Monday trading, dropping $3.65 to close at 70 cents.

                      In October 2005, Sonus sold 15 percent of the company to Schering AG of Berlin and granted the German drug maker an exclusive worldwide license for the drug.

                      “We are profoundly surprised and disappointed that Tocosol Paclitaxel did not achieve the primary endpoint of this pivotal trial, particularly given the efficacy and safety results from previous clinical studies of our drug,” said Michael Martino, president and CEO of Sonus, in a statement.

                      http://www.bizjournals.com/seattle/stories/2007/09/24/daily2.html

                       

                       

                      Bayer grabs Emeryville site to protect top-selling drug In a move to safeguard its top-selling drug, Bayer AG will take control of a former ChironCorp. production facility in Emeryville, making Bayer the Bay Area’s second-largest biotech employer . It is the second time in 17 months that the facility that produces Bayer’s injected multiple sclerosis drug Betaseron has changed hands, assuming the U.S. Food and Drug Administration approves the changeover. And it comes as Betaseron’s patent protection nears expiration. Bayer is locking in production and royalties fromNovartis AG, which is selling the former Chiron facility and launching its own version of the drug. The deal, with points still being negotiated, allows Bayer’s Berkeley biotech subsidiary, Bayer HealthCare Pharmaceuticals, to add 550 people, and gives Bayer greater control over its Betaseron business, which had second-quarter sales of $353.7 million. “This is a different environment, but it’s still an exciting opportunity,” said Alfred Merz, who heads Bayer’s Emeryville transition team. “It’s really forward-looking.” As Novartis brings its version of Betaseron to the market in 2009, Bayer will produce it, shed the royalties it currently makes to Novartis, and, instead, receive royalties from the Swiss drug giant.

                       

                      Bayer, says Michael Schuppenhauer, a biotech consultant in Half Moon Bay, must prove it has the attention span to build a strong biotech business. Bayer doesn’t appear to know its long-term strategy, he said. “Bayer has a lot of strategic decisions to make and a lot to do in their pipeline to be a serious, good biotech player,” he said.

                       

                      Meanwhile, Novartis is expected eventually to market an oral multiple sclerosis drug that could be made elsewhere, whittle Bayer’s MS drug market share and Bayer’s Betaseron royalty receipts. Plus, other companies – including Alameda’s Pepgen Corp. and Palo Alto’s Bayhill Therapeutics Inc., both of which have products in Phase 2 clinical testing – are working on new-generation drugs for an MS market valued by drug-development companies at more than $5 billion. At the same time, Bayer is digesting last year’s acquisition of Schering AG, and rumors have surfaced that Novartis is targeting Bayer as a merger target.

                      Novartis Vaccines & Diagnostics took control of the Emeryville site with the purchase last year of Chiron. That triggered a provision that allowed Schering – and ultimately Bayer – to take over the section of the complex that produces Betaseron. Novartis will continue to occupy 90 percent of that complex. Upon leasing the Betaseron facility to Bayer, Novartis will employ about 1,200 people in the Bay Area. Chiron had 2,400 local employees when Novartis bought it in 2006.

                      http://www.bizjournals.com/eastbay/stories/2007/09/17/story15.html?page=all

                       

                      Jun 19, 2007, 3:06pm EDT

                      Bayer raises projections

                      Bayer AG raised its profit forecast for the next three years, in part due to the acquisition of Schering AG.

                      The German drug company increased its profit margin estimate to more than 20 percent this year, from 19 percent previously, saying the Schering purchase will allow it to cut costs by $134 million more than forecast.

                      Bayer Corp. has its U.S. headquarters in Robinson Township, outside Pittsburgh.

                      http://www.bizjournals.com/pittsburgh/stories/2007/06/18/daily13.html

                       

                      Mar 15, 2007, 12:49pm EDT

                      Bayer profit surges

                      Bayer AG, Germany’s largest drugmaker, said fourth-quarter profit surged almost sevenfold, propelled by revenue from a multiple sclerosis treatment and birth-control pills gained in the purchase of rivalSchering AG.

                      Net income increased to $411 million, or 41 cents a share, compared to nearly $60.9 million in the same period a year ago.

                      Fourth quarter revenue totaled $10.5 billion in 2006, up 25 percent from the $8.4 billion the company reported in the 2005 fourth quarter.

                      Sales in North America advanced by 19.8 percent in 2006. In this region, improvements were recorded by HealthCare, thanks to strong sales in the Consumer Health segment, as well as by MaterialScience in the Polyurethanes business unit and in Coatings, Adhesives, Sealants.

                      http://www.bizjournals.com/pittsburgh/stories/2007/03/12/daily26.html

                      Bayer’s Failure to Warn

                      Failure to warn is a legal term in tort law. It holds product manufacturers, suppliers, distributors, and retailers responsible for any injuries that may have been directly caused by their products. Under the failure to warn tort, parties associated with a product’s manufacturing and distribution have failed to emphasize a product’s inherent dangers to the public.

                      Bayer’s Deceptive Advertising

                      In addition to failure to warn claims, plaintiffs argue that Bayer’s advertising for Mirena was misleading. The advertising tactics allegedly misrepresented the benefits that Mirena could provide to its users. The advertising also concealed harmful side effects that resulted from Mirena use. Mirena complications can lead to serious injuries, surgery, infertility, and possible death! http://www.mirenalawsuit2013.com/mirena-lawsuits/

                      Risks Associated with Migration

                      The IUD can puncture and pass through the uterine wall, allowing it to travel to other parts of the body and cause serious internal injuries, such as:

                      abscesses, damage to internal organs, ulcers, embedment in the uterus, – dystrophic calcifications, infertility, Hysterectomy, inflammation of the membrane lining the abdominal cavity (peritonitis), Lymph Node Swelling, intestinal perforations or obstruction, ovary/fallopian tube damage – endometrium, hyperplasia, PID, hair loss, and loss of libido. The complications from the Mirena IUD also have resulted in infections, which could be potentially life threatening –Continuous Abnormal Paps

                      Bayer’s cost-cutting medicine is helping cure an entrepreneurial itch for one of its longtime executives.

                      Wolf Busse, a 28-year veteran of the German drugmaker, started ACT Biotech Inc. in late April to develop and market oral cancer drugs from more than 300 compounds licensed from Bayer HealthCare LLC. That includes a Phase II compound that could net a cancer drug as early as 2013.

                      The licensing deal, on top of $12 million in early venture capital financing, comes as Bayer continues to digest its 2006 purchase ofSchering AGfor $20 billion. Bayer, wanting to shed more than $900 million in combined annual costs, will close its West Haven, Conn., research facility and unload many of the drugs that were under development there. Busse opened the facility as Bayer’s first R&D operation in the United States.

                      Busse and Mahoney worked together at Bayer, including building a partnership with Onyx Pharmaceuticals Inc.of Emeryville on a compound that would become the cancer drug Nexavar. That drug also was a focus for Fattaey, who was vice president of research and development at Onyx for three years.

                      It’s the second time Busse has built a business on Bayer’s surplus compounds. He left Bayer in 2004 to start Aerovance as a respiratory and inflammatory drug development spinoff from Bayer compounds. That also came with the financial backing of NGN Capital.

                      It was NGN, which Busse joined as a venture partner after leaving Aerovance management in late 2005, that invested $12 million in the first tranche of ACT financing. Bayer has a 20 percent stake as well, and the Melanoma Therapeutics Foundation has a minority stake.

                       

                      Meanwhile, Busse said the melanoma foundation and its mission is not lost. The foundation targets a cancer that will strike an estimated 62,000 people in the United States this year, killing more than 8,400.

                      Of the three or four compounds on which ACT is zeroing in on, the company has committed to developing at least one drug candidate for melanoma, Busse said. That would be an achievement, given that all potential melanoma treatments over the past decade have failed in late-stage clinical trials.

                      Negligence is historically a tort concept. With respect to product liability, manufacturers are liable for their failures to exhibit ordinary care to any party who suffered an injury that was proximately caused by that manufacturer’s negligent conduct. In what specific ways can a manufacturer be found negligent in conduct? There are five main ways, including through:

                      Design of the product = assembly and testing of a product = placement of inadequate warnings, labels, directions, or instructions on a product’s packaging, such that ordinary and average consumers and users are unaware of dangers or risks of harm associated with using the product –

                       

                      Please Read Below Conspiracy – Bayer AG aka Bayer Healthcare akd Berlex aka Schering Impacting the American pharmaceutical Market

                       

                      You will view the Int’l hidden pharmaceutical agenda with Europe-Germany infiltrating U.S. Markets

                      1979: Company is formed by Schering AG. – 1982:Berlex enters the imaging market.- 1988: Trademark suit settled with U.S.-based Schering Corporation. – 1990: Biotech Codon and Triton Biosciences acquired.

                      1997: Headquarters is moved to Montville, New Jersey.

                      Berlex Laboratories, Inc. is a Montville, New Jersey-based subsidiary of German pharmaceutical Schering AG. Berlex markets some 20 products, such as an oral contraceptive called Yasmin and medicines used to treatmultiple sclerosis, dermatological disorders, and cancer.The companyalso offers diagnostic imaging agents used in performing MRI scans. Berlex’s bioscience division is located in Richmond, California. Generating about $1.2 billion in annual sales, Berlex contributes about one-quarter of its parent corporation’s total revenues.

                      Although Berlex was founded in 1979, the roots of the company date back to the mid-19th century when Ernest Schering open a pharmacy in Berlin, Germany. He would incorporate the business in 1871 as Chemische Fabrik auf Actien and become involved in the production of chemicals, such as mercury compounds, that had uses in both pharmaceuticals and photography. In 1890, a year after Schering died,the company launched its first specialty product, a treatment for gout.

                      Over the next few decades,the company diversified into such areas as electroplating for decorative metals, industrial and laboratory chemicals, and agrochemicals. In the 1930s it merged with a mining and chemical company and the resulting entity was renamed Schering AG. From its earlier days,the companywas active in the United States. A subsidiary, Schering & Glatz, was launched in 1876 to distribute medicines produced by the parent company. However, 40 years later during World War I when the United States and Germany became enemies, the German-owned subsidiary was dissolved.

                       

                      Schering returned to the U.S. market in 1929 by establishing New York City-basedScheringCorporation, a subsidiary that focused on hormone research and synthesized steroid drugs. When Germany and the United States were once again pitted against one another in World War II,the companycame under scrutiny, largely because itscorporateparent was suspected of working closely with the Nazis to produce drugs that might help German pilots to withstand the strains of high altitudes, thus giving them the tactical advantage of being able to fly higher. In 1942 Schering’s U.S. subsidiary was seized by the U.S. government, and some ten years later the government elected to sell the business to a private investment group headed by Merrill Lynch. As a result, the U.S.-based ScheringCorporationwas separated from Schering AG.

                      Schering AG struggled to rebuild its business during the difficult conditions that prevailed following the war.The companyused its expertise in steroids to produce the first birth control pill, simply known as “the Pill,” introduced to the European market in 1961. With the profits from this product, Schering was able to diversify and one again try the U.S. market. In 1972 it acquired a half-interest in New Jersey-based Knoll Pharmaceutical, the first of several acquisitions Schering would make in the United States over the next several years.

                      In 1990 Schering entered the U.S. biotechnology sector by acquiring two San Francisco-area companies: Triton Biosciences and CodonCorporation. A subsidiary of Shell Oil Company, Triton pursued anti-cancer drugs. However, its increasing demands for more funding, without any viable products toshowfor all of its efforts, had convinced Shell that it would be better off concentrating on its core competency, and it willingly sold the biotech to Schering. Triton had an upside for Schering in that it had two products in clinical trials: Fludara, used in the treatment of refractory chronic lymphocytic leukemia, and Betaseron, a treatment formultiple sclerosis. Established by college professors, Codon raised money by hiring out the expertise of its personnel.

                      The California start-up mindset sometimes clashed with the sensibilities of the Germancorporateparent, the executives of which were more conservative by nature and believed the Americans were moving ahead on projects too quickly. To address this problem and forge better understanding between the two cultures, a work exchange program was established, allowing employees to spend up to one year at an assignment outside their home country.

                       

                      Also in 1993, Berlex introduced Betaseron, a breakthrough in the treatment of multiple sclerosis developed in conjunction with Chiron Corporation. (The product was manufactured by Chiron and sold by Berlex.) A genetically engineered form of interferon, a protein produced by the body to fight viruses, Betaseron was the first medication developed that could reduce the number of spikes in the disease, which could greatly worsen such symptoms as tremors, fatigue, and numbness. The drug Climara, a patch, was another first for Berlex when it was launched in 1995. Climara was the first transdermal estrogen replacement therapy product. The seven-day patch delivered estrogen to women directly into the blood stream, especially useful in the prevention of osteoporosis.

                      Betaseron – http://www.bigclassaction.com/lawsuit/betaseron.phpBetaseron (interferon beta-1b) is a medication approved by the FDA for the treatment of relapsing forms of Multiple Sclerosis, as a therapy to reduce the frequency of symptomatic exacerbations. Berlex, Inc., the manufacturer of the medication, recently contacted healthcare professionals to remind them about certain aspects of the prescribing information for Betaseron as it relates to liver toxicity.

                       

                      Bayer Warns Betaseron Packaged With Recalled Alcohol Prep …http://www.aboutlawsuits.com/betaseron-prep-pad-warning-15709 – Jan 21, 2011 · Bayer Healthcare Pharmaceuticals is warning consumers and doctors thatBetaseron, a multiple sclerosis medication, was shipped with recalled alcohol prep p

                       

                      Climara Pro®(estradiol/levonorgestrel patch) is a prescription estrogen and progestin hormone replacement medication. It is approved for the following uses – Generic Climara Pro

                      There is currently no generic Climara Pro approved in the United States. A patent prevents any generic versions of the medication from being made until at least 2014. However, certain circumstances could come up that would delay or speed up the availability of generic Climara Pro, such as lawsuits or other patents for specific uses. healthquestions.medhelp.org/climara-lawsuits

                      VERY DISTURBING WOMEN OF AMERICA:

                      Information About Ethinyl Estradiol and Yaz Lawsuithttp://howdrugs.com/information-about-ethinyl-estradiol-and-yaz-lawsuit/

                      Related posts: (Look how these corporations are intermingling chemicals)

                      1. Norgestrel and Ethinyl EstradiolEthinyl Estradiol In Yaz Linked To Side Effects

                      2. Levonorgestrel and Ethinyl Estradiol

                      3. Norgestimate and Ethinyl Estradiol

                      4. Desogestrel and Ethinyl Estradiolwww.medicinenet.commenopause a-z listestradiol index

                      5. Drospirenone and Ethinyl Estradiol

                      6. Norgestrel/ethinyl estradiolmenopause.emedtv.com/climara-pro/generic-climara-pro.htm

                      Please continue reading more Berlex Information acquired by Bayer AG aka Bayer Healthcare: Additional pharmaceutical conspiracies in America

                      In the final years of the 1990s, Berlex moved to new headquarters in Montville, New Jersey, and introduced several new products. It launched Levlite in 1998, an oral contraceptive with a lower dosage than Levlen. In 1999 Climara became available in a new low-dose form. Another new Berlex drug, also launched in 1999, was Quadramet, used to treat the pain that accompanied metastatic bone cancer. In addition, Berlex acquired two new diagnostic imaging products in 1999: Acutect and Neotect.

                      Cytogen, DuPont Merck End Quadramet Agreement.(pain killerhttp://www.highbeam.com›Chemical Week June 1998 Jun 17, 1998· Biopharmaceutical maker Cytogen says it has ended a licensing agreement with DuPont Merck for… | Article from Chemical Week June 17, 1998

                      QUADRAMET(TM) NEW DRUG APPLICATION FILED BY FDA – http://www.thefreelibrary.com/QUADRAMET(TM)+NEW+DRUG+APPLICATION+FILED+BY+FDA-a017145077

                      QuadraMed back on Wall Street | Healthcare IT News

                      http://www.healthcareitnews.com/news/quadramed-back-wall-street

                      Sep 10, 2004 QuadraMed has bounced back from delisting, shareholder lawsuits, a fraud investigation and financial troubles to once again see its stock traded on Wall …

                      http://www.thefreelibrary.com›BusinessPR Newswire May 26, 1998

                      May 26, 1998 · Free Online Library: DuPont Merck and CYTOGEN Announce Continued Collaboration On Quadramet by “PR Newswire”; Business News, opinion and …

                      http://www.pharmagazette.com/quadramet

                      QUADRAMET® Archives. Advertise. Watch the Digital Health Revolution. …Lawsuitsand Litigations; Manufacturers & Mergers; Medical Conditions; Medical Products; News;

                      http://www.healthcare-informatics.com/news-item/updated-quadramed-ceo-ncr…

                      Earlier today, QuadraMed, … Merge Healthcare, the Chicago-based provider of imaging informatics software, is facing separate lawsuits from stockholders, …

                      http://www.icis.com/Articles/1998/06/08/60346/dupont-mum-on-3.8m-cytogen…

                      The companies now say DuPont Merck will manufacture Quadramet over the next two years while Cytogen will expand … 27 May 98 16:39 Cytogen drops DuPont Mercklawsuit;

                      DuPont Merck/Cytogen Keep Quadramet Deal … Cytogen has withdrawn a lawsuitagainst DuPont Merck Pharmaceutical Coregarding the latter’s obligations …

                      History of Berlex Laboratories, Inc. –FundingUniversewww.fundinguniverse.com/company-histories/berlex-laboratories-inc…Acutectand Neotect. … “Bogen to Pay $55 Million in Deal To Settle Schering PatentLawsuit,” Wall Street Journal, February 4, 2003, p. B7. Sellers, …

                      Welches Image hat ACUTECT? | Bewertungen, Nachrichten http://www.brandigg.de/brand/ACUTECT

                      Das Image der Marke ACUTECT. Lesen Sie Bewertungen, … related keywords: angiomax claim, angiomax lawsuit, home decore stores angiomax law suit, …

                      2001 Berlex launched five products: Campath, used to treat B-cell chronic lymphocytic leukemia; Refludan, a thrombin inhibitor used to treat patients with heparin-induced thrombocytopenia and associated thromboembolic disease; Finevin, an acne medication; Mirena, an implanted contraceptive; and Yasmin, an oral contraceptive. Additionally in 2001 Berlex acquired Refludan, a direct thrombin inhibitor used to treat patients with heparin-induced thrombocytopenia. A year later Berlex acquired Leukine, prescribed for older adults with acute myelogenous leukemia following chemotherapy, after bone marrow transplantation, or peripheral blood stem cell transplantation. In 2003 Berlex introduce Finacea, a topical treatment for rosacea.

                      CampathLawsuit– Do I Have A Lawsuit Lawyer Attorney Legal

                      doihavealawsuit.com/70-united-states/massachusetts/234-campath

                      Campath Lawsuit Campath Side Effects Campath is an alemtuzumab injection for intravenous use. Campath (alemtuzumab) is a recombinant DNA-derived humanized …

                      Campath, used in the treatment of leukemia, has been reported to cause ITP, a dangerous autoimmune disease.

                      • CampathLawsuitdoihavealawsuit.com/…/234-campathlawsuit.html Campath Lawsuit Campath Side Effects Campath is an alemtuzumab injection for intravenous use. Campath (alemtuzumab) is a recombinant DNA-derived humanized …

                      Refludan– Cancer News Network

                      http://www.cancernewsnetwork.org/medications/rx/Refludan.html

                      RefludanThis page contains recent news articles, when available, and an overview ofRefludan but does not offer medical advice. You should contact your physician …

                      wiki.legalexaminer.com/topic/refludan-lepirudin-overview.aspx

                      InjuryBoard News:Refludan/ Lepirudin – Find trial lawyers and attorneys with experience in lawsuits involving Refludan/ Lepirudin. Contact an attorney who can help …

                      http://www.thefreelibrary.com›…›PR NewswireOctober 1, 2001

                      Oct 01, 2001· Free Online Library: Regulatory Agencies Approve Aventis Sale ofRefludan(R) … The act or process of bringing a lawsuit in and of itself; …

                      http://www.thefreelibrary.com›BusinessPR NewswireJuly 1, 1998

                      Jul 01, 1998 Refludan fills a gaping hole in the management of this potentially life-threatening condition … The act or process of bringing a lawsuit in and of …

                      rxrecall.com/news/pradaxa

                      argatroban (Acova), bivalirudin (Angiomax), lepirudin (Refludan); dalteparin (Fragmin … our Pradaxa attorneys have handled countless lawsuits involving harmful …

                       

                      Edgar Filing: DUSA PHARMACEUTICALS INC – Form 10-K

                      finance.boston.com/boston/action/getedgarwindow?accesscode=…

                      Except for the Levulan ® Kerastick... of aminolevulinic acid HCl as an alternative to ourLevulan ® product. We have filed lawsuits against 2 compounding …

                      http://www.thefreelibrary.com›…›Business WireNovember 21, 2005

                      Nov 21, 2005· Free Online Library: DUSA Pharmaceuticals Sues Physicians For Infringement of its Levulan‘R’ Photodynamic Therapy Patents. by “Business Wire”; …

                       

                       

                      http://www.thefreelibrary.com›…›Business WireJanuary 23, 2006

                      Jan 23, 2006· Free Online Library: DUSA Pharmaceuticals Sues Additional Physicians For Infringement Of Its Levulan‘R’ Photodynamic Therapy Patents. by “Business Wire …

                      History of Berlex Laboratories, Inc. FundingUniverse

                      http://www.fundinguniverse.com/company-histories/berlex-laboratories-inc…

                      .Finevin, an acne medication; Mirena, an … “Bogen to Pay $55 Million in Deal To Settle Schering Patent Lawsuit,” Wall Street Journal, February 4, 2003 …

                      http://www.medilexicon.com›fda approved drugs

                      Finevin Topical cream for the treatment of mild to moderate inflammatory acne vulgaris Firazyr (icatibant) For the treatment of acute attacks of hereditary …

                       

                      Welches Image hat FINELACT? | Bewertungen, Nachrichten …

                      http://www.brandigg.de/brand/FINELACT

                      FINEVIN. 5. FINISH BRILLIANT. 6. Finnmatkat. 7. Finocarbo plus. 8. FINPLUS. 9. FINSEC. 10. fiorenzato. 11. Fiori Tristano Onofri. 12. FIRE TOP. 13. Firma Partnerska …

                       

                      Topical Testosterone Cream Side EffectsEat Stop Eat | Eat …

                      ieatstopeat.info/tag/topical-testosterone-cream-side-effects

                      Google: Hair growth caused other men nationwide in class-action lawsuits. About 1,640,000 results …Finevin, Skinoren) is suitable for mild, comedonal acne.

                       

                      Acne Therapies. (Drugs, Pregnancy, and Lactation)Topical and systemic agents are used in the treatment and prevention of acne, ranging from those that have negligible risks during pregnancy to a drug that is a major teratogen. Azelaic acid (Azelex, Finevin), a topical antimicrobial, agent, is rated pregnancy risk factor B. It is embryotoxic in animals, but only at maternal toxic doses http://www.thefreelibrary.com/Acne+Therapies.+(Drugs%2c+Pregnancy%2c+and+Lactation).-a098830100

                       

                      Leukine FDA Recall Alert Warning on Side effects of Leukine

                      http://www.resource4thepeople.com/defectivedrugs/leukine.html

                      a recall by the manufacturer of Leukine from the American market the FDA is helping the manufacturer publicize this issue.

                      http://www.pharmawatchdog.com/leukine-sargramostim-2

                      Bayer and FDA informed healthcare professionals of the market withdrawal of the current liquid formulation of Leukine, a growth factor that helps fight infection and …

                      http://www.kerrysteigerwalt.com/public/defectivedrugs/lamisil.html

                      Leukine; Meridia; Mesothelioma Lawyer; Metabolife; Mirapex; … Law firms are taking inquires from people who may have a potential yasmin lawsuit due to injury from …

                      injury-action.com/class-action-lawsuits-against-enbrel

                      View Document lawsuits filed against Eli Lilly. (Aranesp, Epogen, Neulasta, Neupogen, Enbrel and Leukine). No. BC409095 (Cal. Super. Ct.). A class action complaint …

                       

                      Bayer sues Glenmark over generic Finacea– Life Sciences … BERLEX?

                      http://www.lifesciencesipreview.com/…sues-glenmark-over-generic-finacea

                      Pharmaceutical companies Bayer, Intendis and Intraserv have filed a patent infringement lawsuit against Glenmark after it applied to market a generic version of …

                      rosacea.emedtv.com/finacea/generic-form-of-finacea.html

                      If your healthcare provider prescribesFinacea ® (azelaic acid gel) to treat rosacea, you may be wondering if there is a generic version available.

                       

                      Accutane RosaceaLawsuit Gretchen Calcao Jessie Samuell …

                      laosind.appspot.com/?cheap=accutane.rosacea.lawsuit

                      Accutane RosaceaLawsuit Arden Gollman Valda Shilling Isidro Caulfield Alvina Pasternak Everette Varas Nicolas Serrano Julienne Cerva Orval Macalma Fransisca …

                       

                      Nuvaring LawsuitsRosacea Group

                      www.rosaceagroup.org/The_Rosacea_Forum/…30179-Nuvaring-Lawsuits

                      This is off topic too, so moderators please feel free to remove it if you deem fit, but there is controversy at the moment about the Nuvaring, a hormonal …

                       

                      Seroquel LawsuitsAboutLawsuits.com  http://www.aboutlawsuits.com/seroquel-951

                      Nov 01, 2010 · Seroquel lawsuits have been pursued by individuals who have suffered any of the following side effects from the drug: Diabetes; Pancreatitis; Tardive …

                       

                      After 25 years, Berlex was a clear success for Schering, one of the few European drug makers to crack the U.S. market. The winning strategy was to become a niche company, to focus on specific product lines, such as birth control and multiple sclerosis, rather than to attempt to compete with much larger companies over a broader front.

                      AMERICA CITIZENS: If you read to the bottom of this article you will see the disturbing pharmaceutical nightmare in America by all of the New Top Pharmaceutical Corporations in America! Bayer AG aka Bayer Healthcare, Merck aka Merck KgAA, Novartis AG, Schering, Berlex, Pfizer, AstraZeneca, Glaxo Smith Kine and many more! The multiple mega mergers and hand me down drugs are impacting and killing many American citizens! Also it could be possibly true the increase in medical drugs and services in America are in the hands of all of these international top American Pharmaceutical Leaders controlling the United States Markets! 

                      PLEASE DO YOU DUE DILIGENCE AMERICA MEN AND WOMEN BEFORE TAKING ANY PHARMACEUTICAL DRUG OR IT MAY COST YOU, YOUR LIFE!! THIS ARTICLE WAS PRODUCED FOR EDUCATIONAL PURPOSES ONLY TO HELP SAVE AMERICAN LIVES! 

                      Women Are Paid Less Than Men Not Because of Discrimination https://www.youtube.com/watch?v=IMkDEe8ypfU

                      News Update: Novartis Loses Gender Discrimination Lawsuit https://www.youtube.com/watch?v=4Vjuwgbv5jc

                      Sexual Discrimination, Maternity Leave and Hostility, and a Large Legal Settlement https://www.youtube.com/watch?v=UfCh5RCDg9M 

                      Gender Discrimination at Job Interview https://www.youtube.com/watch?v=Eb-AqnwOTxE

                      Federal Judge Reveals Judicial Corruption https://www.youtube.com/watch?v=SPXfYWKFME8

                      “ALEC (American Legislation Exchange Council) Protest at Westin Kieland Resort” pt.1 of 2 https://www.youtube.com/watch?v=QcNeojyMZ7I

                      Drugs, Money and Power: Big Pharma – STDWYTK – https://www.youtube.com/watch?v=l5qhvfMRHqI

                      Making a Killing: The Pharmaceutical Industry Pt 1/3 – https://www.youtube.com/watch?v=5sjajVVEzoE

                      Bill Schnoebelen – The Medical Conspiracy https://www.youtube.com/watch?v=GSQwS1Hf0yE

                      ALEX JONES dénonce la conspiration de big pharma https://www.youtube.com/watch?v=uoRh9jsL6Wo

                      Population Controls, Eugenics, Root Race Theory & Social-Spiritual-Racial Evolution – https://www.youtube.com/results?search_query=Eugenics+Theory&sm=3

                      Goverment Eugenics Program – https://www.youtube.com/watch?v=U_uO8fW5dsQ

                      Victims of a eugenics sterilization program in North Carolina speak out – https://www.youtube.com/watch?v=0exeyPb5BiA

                      Eugenicist Movement in America: Victims Coming Forward – https://www.youtube.com/watch?v=Nshj9rCTPdE

                      Sex Control Police State, Eugenics, Galton, Kantsaywhere, Mind Control Report https://www.youtube.com/watch?v=8_l6gbgzwRY

                      EUGENICS U.K. – Elderly & Disabled Cut Out Of Social Care System https://www.youtube.com/watch?v=wkPjDcflPCc

                      D.O.V.E. Research BIRTH CONTROL EUGENICS https://www.youtube.com/watch?v=SCvhDRMbjNI

                      Image

                      CABIRI, 

                      Web Content Freelance Writer & Corporate Research

                       

                      Eugenics Theory – Male Sterilization

                       Men of America, Eugenics Theory Sterilization applies to you also, please view below many medical disparities that will Alarm you personally and emotionally!

                      Many American males may not be aware of the numerous Internationally controlled, “Big Pharma” lawsuits in the United States,” which impacts millions of American males livelihoods,  right the to reproduce, and possibly cause permanent life altering deadly problems.

                      The top American International pharmaceutical corporations are experimenting with various drugs via human beings, which are not only impacting women, also men. Please view all of the links below see the disturbing medical impacts that may hit home to you and your family! Before taking any drug please do your own due diligence for your own health, safety and well-being, if possible try natural healing and home remedies, “Like grandma or your mother may have taught ya”!

                      View Below International U.S. Big Pharma Male Lawsuits:
                      Axiron & Heart Attack or Stroke – Axiron is a topical testosterone replacement therapy (TRT) gel manufactured by Lilly USA, Inc. Axiron is a prescription medication that treats “Low T,” or low testosterone levels in men. Symptoms of Low T can include decreased strength and energy, mood changes, decreased libido, and erectile dysfunction.
                      Axiron was approved by the Food and Drug Administration in November 2010 and remains the only TRT product that is applied directly to the underarms. http://www.girardgibbs.com/axiron-lawsuits/

                      Testosterone Lawsuit News: Second Testim User Files Testosterone TreatmentLawsuit in Pennsylvania State Court, Bernstein Liebhard LLP Reports

                      Among other things, the lawsuit claims that Auxilium Pharmaceuticals Inc. and GlaxoSmithKline knew or should have known about the cardiovascular risks associated with Testim, including myocardial infarction,…

                      Testosterone therapy lawsuits are appearing more frequently as thousands of men report injuries shortly after beginning treatment. New research has shown the increased risk of complications in men that have been undergoing testosterone therapy, or low T treatment. The treatment, intended as a supplemental therapy for men with hypogonadism, could cause increased risk of ischemic stroke, myocardial infarction (MI) or even death.
                      On January 31, 2014, the U.S. Food and Drug Administration released a safety announcement warning consumers of the potential risk of testosterone therapy and announced that they will be conducting further investigation. Concern arose from two published studies that indicate higher risks of adverse effects in patients within the first three months of treatment. http://www.drugdangers.com/testosterone/lawsuit.htm#sthash.pcwtmsdd.dpuf

                      Axiron Lawsuit – http://www.axironlawsuit.com/
                      If you’re a middle-aged or older man, you’ve probably seen commercials urging you to talk to your doctor about testosterone replacement therapy (TRT). If you’re feeling tired, depressed, or lacking in sex drive, the commercial tells you, you may be suffering from low testosterone and could benefit from a supplement like Axiron. What the commercials don’t tell you is that testosterone boosters have recently been linked to serious side effects including heart attack, stroke, blood clots, and death.

                      Manufactured and marketed by Eli Lilly, Axiron was approved by the FDA in 2010. Sales reached nearly $50 million the following year, and the company spent twice that on a marketing campaign to promote the entire TRT industry. The target audience of these ads were men over the age of 30, the approximate age at which testosterone levels begin to decrease.
                      Testosterone Lawsuit News: Second Testim User Files Testosterone Treatment Lawsuit in Pennsylvania State Court

                      Read more: http://www.virtual-strategy.com/2014/03/25/testosterone-lawsuit-news-second-testim-user-files-testosterone-treatment-lawsuit-pennsyl#ixzz2x7uwlKbd
                      Read more at http://www.virtual-strategy.com/2014/03/25/testosterone-lawsuit-news-second-testim-user-files-testosterone-treatment-lawsuit-pennsyl#qplwXzrGTxM6MmUA.99

                      Court documents filed in the U.S. District Court, Northern District of Illinois indicate that five AndroGel lawsuits are currently pending in that jurisdiction. These include four cases filed on February 4th on behalf of men who allegedly suffer heart attacks, strokes and heart failure due to their use of the medication.

                      (Case Nos: 1:14-cv-00776, 1:14-cv-00780, 1:14-cv-00777, and 1:14-cv-00772) The Fifth AndroGel lawsuit was filed on February 10th and claimed that the Plaintiff suffered pulmonary embolism, deep vein thrombosis, and other serious cardiovascular injuries after using multiple doses of the drug. (Case: 1:14-cv-00917)

                      All of these filings followed an alert issued by the U.S. Food & Drug Administration (FDA) on January 31, 2014, that revealed the agency had undertaken a review of low testosterone therapies, after two studies indicated the drugs might increase the risk for heart attacks, strokes, and sudden death in certain men.

                      http://www.virtual-strategy.com/2014/03/25/testosterone-lawsuit-news-second-testim-user-files-testosterone-treatment-lawsuit-pennsyl

                      AndroGel Class Action Lawsuit 2014
                      Our unsafe prescription drug side effect law firm is currently investigating possible class action and single party claims against manufacturers of testosterone medications including AndroGel for the development of harmful side effects amongst users. In 2000 AndroGel 1.0% was approved by the FDA. Since then several studies have shown a significant, 30% in some cases, increase in the risk of Coronary Angiography and other cardiac based illnesses. In response the FDA issued a black box warning for the product in 2009. According to recent FDA warnings the use of AndroGel 1% and AndroGel 1.62% manufactured by Abbot Laboratories can result in cardiac complications including, heart attack, stroke, and pulmonary embolism.

                      Androgel Manufacturers Face Class Action for Antitrust Violations
                      A class action complaint filed last week in New Jersey federal court claims damages for violations of the Sherman Antitrust Act by brand-name and generic manufacturers of the drug, Androgel.

                      The suit alleges that brand name and generic manufacturers conspired to fix and raise the price of Androgel, by overcharging Plaintiffs and others by millions of dollars and depriving them of cheaper generic versions of the drug. The complaint estimates that hundreds or thousands of people or companies have been economically injured by the drug manufacturers’ conduct.

                      http://www.bigclassaction.com/lawsuit/androgel-class-action-antitrust.php
                      Propecia Side Effects – Lawsuits have been filed against Merck & Co. aka Merck KgaA alleging seriousPropecia side effects including Propecia sexual dysfunction and other Propecia side effects in men. Among allegations in the most recent Propecia lawsuit are that Propecia (Finasteride) can cause anxiety attacks and insomnia.

                      Plaintiffs allege that Propecia long term side effects, such as the emotional symptoms, remain years after patients have stopped taking the medication. Some Propecia patients may be taking Proscar, which is a higher dose version of finasteride. http://www.lawyersandsettlements.com/lawsuit/propecia.html#.UzOShPldXww

                      Two Navy Veterans Win Asbestos Mesothelioma Settlements
                      New York, NY: The lawsuits of two men who alleged a lifetime of working with asbestos led to their developing mesothelioma, a rare cancer that attacks the lining of the lungs have been successfully settled. http://www.bigclassaction.com/settlement/navy-veterans-asbestos-mesotheliom..

                      Risperdal Gynecomastia (Breast Development in Males)
                      The antipsychotic drug has also been linked to an increased risk of young males developing gynecomastia, an increase in breast tissue. This condition is thought to be caused by increased levels of prolactin, a hormone involved in lactation and increased in Risperdal patients. In November 2008,The Wall Street Journal reported that Risperdal can stimulate the production of prolactin.

                      Although Risperdal carries a warning about the risk some doctors have called on the FDA to strengthen the warning. Boys who have developed gynecomastia may experience pain or nipple discharge. Mild cases can be resolved with liposuction, while more severe cases will require a mastectomy.

                      http://www.lawyersandsettlements.com/lawsuit/risperdal.html#.UzOTxfldXww
                      http://www.lawyersandsettlements.com/articles/risperdal/interview-risperdal-lawsuit-side-effects-3-19603.html#.UzOUz_ldXww

                      Canada’s Supreme Court strips Viagra patent from Pfizer
                      http://www.reuters.com/article/…/us-viagra-idUSBRE8A70XG2012110… Nov 8, 2012 – A box of Viagra, typically used to treat erectile dysfunction
                      In the past, Pfizer has successfully defended patent lawsuits from Teva
                      NAION: Another Name for a Serious Condition Pfizer, the manufacturer of Viagra, faces numerous defective drug lawsuits claiming they failed to adequately warn the public about the dangers of NAION, the acronym for a condition known as “non-arteritic anterior ischemic optic neuropathy,” also called eye stroke. Pfizer has argued that no evidence exists linking Viagra to NAION, but attorneys are seeking a class action lawsuit on behalf of the 24 million men who have used Viagra since it came on the market.

                      Viagra lawsuits focus on physician reports claiming Viagra affects blood circulation to the optic nerve, resulting in vision loss. Attorneys are seeking to force Pfizer to place a ‘black box’ warning on the drug’s label, the strongest warning any medication can receive. Use of Viagra has been linked to; Sudden death – Cardiac events – Blindness – A sudden drop in blood pressure in some patients

                      Generic Viagra’s US Launch Set for 2017 as Teva, Pfizer Settle genengnews.com/gen-news…viagra-s…pfizer…lawsuit/81249269/ Dec 18, 2013

                      Viagra’s U.S. Launch Set for 2017 as Teva, Pfizer Settle Lawsuit … and Pfizer agreed to resolve a longtime patent lawsuit over the male – It is not worth your life Gentlemen!!

                      Pfizer Inc. Rigged Canadian Viagra Patent Filing Lawsuit – BioSpace http://www.biospace.com/News/pfizer-inc-rigged-canadian-viagra…/282068 Dec 12, 2012 – Pfizer illegally gamed the Canadian patent system to monopolize the market for Viagra and overcharge customers, a class action claims in.

                      Viagra, Cialis, and Levitra | Dennis Herron and Associates… dennisherron.com/hot-issues/viagra-cialis-and-levitra/ Viagra, Cialis, and Levitra Blindness Class Action Lawsuit. Viagra. Viagra was introduced in 1998 and had $1.68 billion in sales last year. The impotence drug.

                      Cialis (tadalafil) Side effects and lawsuit claims Eli Lilly http://www.resource4thepeople.com/defectivedrugs/cialis.html – by WJ Callahan Mar 6, 2013 – Cialis side effects such as vision impairment and heart pains, lawsuitsfor. … Accutane Lawsuit: Recall Class Action Lawyer…
                      Just for men – Disfigurement, pain, chemical burns, Review 637411 http://www.complaintsboard.com/…/just-for-men-disfigurement-pain-chemical… Oct 19, 2012 – Please include me in any class action lawsuit against Just For Men, my injuries need Justice. I am a public figure in the Fashion Industry,
                      Just For Men Chemical Burns Alleged in Lawsuits Being – PRWeb ww.prweb.com/releases/2014/01/prweb11482171.htm Jan 12, 2014 – Wright & Schulte LLC Launched Just For Men Lawsuit Investigation After … most powerful corporations take responsibility for their actions.
                      http://www.AgelessMaleresettinSettlement.com – Burmeister v NAC http://www.classactionsettlementnews.com/www-agelessmaleresettinsettlement- April 20, 2013 Filed Under: Class Action Lawsuit The Ageless Male lawsuit claim that state and consumer protection laws were violated in … The defendants deny any actions of wrong doing in the case but have agrees to settle.
                      Ageless Male is a Fraud they got sued in a Class Action Lawsuit – https://www.youtube.com/watch?v=x3S6dYFv5uU
                      Penis Enlargement Lawsuits – A New Jersey man has filed a false advertising lawsuit against a maker of herbal penis enlargement pills, alleging the medicine does not fulfill its promises, the plaintiff’s lawyer said on Monday. Two similar cases, filed last year in Colorado and Ohio, accuse manufacturers of herbal dietary supplements, VigRx and Enzyte, of falsely claiming to be able to add substantial length and girth to a man’s penis. All three suits seek class action status and claim to represent more than 1 million total plaintiffs. http://www.4-men.org/penis-enlargement/penis-enlargement-lawsuits.html

                      Proscar Lawsuits Claim Drug Caused Irreversible Sexual Side Effects – Men who suffered from sexual side effects or were diagnosed with prostate or breast cancer following use of Proscar. Damages Proscar sexual side effects can include impotence, problems with orgasm, erectile dysfunction, loss of libido, and ejaculation problems.

                      Proscar has also been associated with the development of prostrate cancer and male breast cancer in users. Merck – Proscar is a drug used to treat enlarged prostate glands. http://www.classaction.org/proscar

                      Finasteride Side Effects, Erectile Dysfunction Lawsuit http://www.yourlawyer.com›Topics› Defective Drugs Finasteride side effects increases erectile dysfunction (ED) risk,lawsuits are being evaluated by Parker Waichman LLP for Finasteride users reporting male sexual …

                      Nationwide Mr. Magic Male Enhancer Recall | Male http://www.schmidtandclark.com/mr-magic-male-enhancer-recall Free Male Enhancement Drug Recall Case … of trial lawyers that focus exclusively on the representation of plaintiffs in male enhancement drug recall lawsuits.

                      Drug Information – DrugAlert.org -Drug Recalls, Drug Lawsuit http://www.drugalert.org Recently, the U.S. Food &Drug Administration called for http://www.HardMenStore.com, an erotic retailer geared towards men, to recall 430 lots of its Silver Sword and Clalis

                      Men Claim Merck Baldness Drug Causes Impotence http://www.breakinglawsuitnews.com/men-claim-merck-baldness-drug-causes…Nine men have filed a lawsuit against Merck for their male pattern baldness drugsPropecia and Proscar, alleging the drugs cause sexual dysfunction, even after they …

                      Lyrica Side Effects Lawsuit – Do I Have A Lawsuit Lawyer doihavealawsuit.com/lawyer-attorney/70-side-effects-lawsuit/382…Lyrica Side Effects Lawsuit.

                      Pfizer’s antiepileptic drug Lyrica has been … the FDA alerted consumers about painful gynecomastia and breast enlargement in male due …

                      http://www.lawyersandsettlements.com/search.html?keywords=male+lawsuits Regenerect Supplement Consumer Fraud Class Action Filed
                      Los Angeles, CA: A consumer fraud class action lawsuit has been filed against Regenerect Natural Male Erectile Stimulant, claiming the product is mislabeled as a “drug-free,” “natural” diet supplement, when it contains active ingredients found in the prescription drugs Cialis and Viagra. According to the lawsuit, the male enhancement pro…

                      Male Power Plus
                      An over-the-counter pill, Male Power Plus, that is used to treat impotence, is being recalled because it may contain the unlabeled prescription drug ingredient tadalafil, which can cause dangerous side effects in people taking nitrates to treat such diseases as diabetes, heart disease and hypertension. Tadalafil, also known as Cialis, was approved by…

                      Nationwide Recall of Dietary Supplements X-Hero and Male Enhancer
                      Mar-28-11 Washington, DC: USA Far Ocean Group Inc is conducting a nationwide recall of the Company’s two supplement products sold under the names X-Hero and Male Enhancer. The Company has been informed by representatives of the Food and Drug Administration (FDA) that lab analysis by FDA of X-Hero sample found the product contains sulfosildenafil, the analogue of…

                      FDA Warns Dietary Supplement Contains Potentially Harmful Synthetic Steroids
                      Washington, DC: The US Food and Drug Administration is advising consumers to immediately stop using a product called Mass Destruction, marketed as a dietary supplement for muscle growth. The product is labeled to contain at least one synthetic anabolic steroid and has been linked to at least one reported serious illness. The FDA was alerted by t…http://www.lawyersandsettlements.com/search.html?keywords=male+lawsuits&page=8

                      Nature & Health Recalls Male Enhancement Products
                      Opteron 1 Inc., doing business as Nature & Health Co., is conducting a nationwide recall of the company’s 5 supplement products sold under the following names: LibieXtreme, Y-4ever, Libimax X Liquid, Powermania Liquid and Capsule, Herbal Disiac. Lab analysis conducted by the the Food and Drug Administration (FDA) of these five samples found they contain…

                      PAXIL DAMAGES DNA IN MEN’S SPERM – http://www.lawyersandsettlements.com/search.html?keywords=male+lawsuits&page=10

                      Investigators Find Paxil Effects Male Fertility New research just released shows that the antidepressant Paxil, also known as paroxetine, has a disturbing and potentially far-reaching effect on men who are taking the drug: it damages men’s sperm through DNA fragmentation, effecting fertility. While the researchers noted that they did not study. Asbestosis – Asbestosis Lung Disease, Asbestosis Lawsuit

                      Asbestosis disease is a serious breathing disorder caused by inhaling asbestos fibers. To ensure asbestosis compensation , it is recommended that you get help from an experienced asbestosis lawyer , who will file your complaint against all your employers and the companies that may have caused asbestos exposure. Asbestosis Asbesto…http://www.lawyersandsettlements.com/lawsuit/paxil-side-effects-fertility.html#.UzO8n_ldXww

                      Family Blames Propecia Finasteride for Son’s Suicide – Montgomery, NJ:A Propecia lawsuit is serious enough, as it suggests ultimate dissatisfaction with a product and the impact it has on an individual. The following case, however, is troubling in that a promising life has been lost, allegedly due to the effects of Propecia finasteride. http://www.lawyersandsettlements.com/articles/propecia/propecia-lawsuit-finasteride-side-6-17827.html#.UzO96fldXww

                      Cialis: Side Effects and FDA Updates – Since its introduction to the market, the FDA has issued two updates regarding Cialis side effects. These warnings have not led to significant litigation against the erectile dysfunction medication. While some people may have obtained a Cialis settlement due to adverse reactions to the drug, these results have not yet been made public.

                      In 2005, the first warning issued by the FDA concerned the risk of developing a vision condition known as NAOIN. This is a temporary or permanent sudden loss of vision in one eye. Many of those who have experienced this Cialis side effect had another contributing condition, such as hypertension. – See more at: http://product-liability.laws.com/cialis-lawsuit#sthash.JrY96nYk.dpuf

                      Cialis Lawsuit Information & Causes – The drug Tadalafil, marketed under the name Cialis, was approved by the Federal Drug Administration, FDA, in 2003 for use as a treatment for impotence and erectile dysfunction in men. Since that time, there have been numerous reports of severe side effects including non-arteritic anterior ischemic optic neuropathy, NAION, blindness and hearing loss http://www.acostawilliams.com/cialis-lawsuit/

                      Prostate Cancer and Male Bladder Sling Implant Problems – Occasionally men need bladder sling implants, especially those that have had prostatectomies, or the removal of the prostate. It can significantly improve longevity, but it also leads to stress urinary incontinence. While some implants do well, synthetic bladder sling implant failures are common among both sexes. http://www.topclassactions.com/lawsuit-settlements/prescription/3474-prostate-cancer-and-male-bladder-sling-implant-problems/

                      Male circumcision lawsuit – antimisandry.com – Articles antimisandry.com/campaigns-news/male-circumcision-lawsuit-10605.html Hmmmm? I hate to dump cold water on you lawsuits because its an important project but such lawsuits will be brushed aside by the agents of Satan in black robes of hell

                      Lipitor Diabetes Lawsuit – http://www.nastlaw.com/lipitor-diabetes-lawsuit/
                      Lipitor FDA Warning In February 2012 the U.S. Food and Drug Administration added new warnings to the labels of

                      Lipitor and other cholesterol drugs. The new warnings were based on the results from a study that showed statins may raise blood sugar levels, leading to memory loss and increasing the risk of developing Type II diabetes. Lipitor has been linked to an increased risk of Type 2 Diabetes.

                      A study by the University of Massachusetts showed women taking lipitor have a 48% higher risk of developing diabetes.The chance of developing diabetes from Lipitor is even higher in women with common risk factors such as obesity, high blood sugar, or a history of family diabetes.

                      Virilis Pro Sued By Adrian Carter For Male Enhancement Pill’s Alleged DISGUSTING Side Effect – If it does, meet Adrian Carter, who claims in a lawsuit filed on Monday that a Virilis Pro pill made his penis bleed and led to a terrifying surgery in which much of his manhood’s skin had to be removed.”During sexual intercourse, plaintiff experienced significant pain and observed a large quantity of blood squirting out of his penis onto the sheets, walls and mirror in the hotel room; his penis and scrotum were visibly swollen http://www.huffingtonpost.com/2012/08/29/virilis-pro-male-enhancement-adrian-carter-lawsuit_n_1840561.html

                      FAQ: Mesh patch injury, symptoms, lawsuits, hernia damage http://www.anapolschwartz.com/practices/surgical-mesh/faq.asp
                      FAQs FAQ: Mesh Patch Injury, Symptoms,Lawsuits, Hernia Damage. I’ve had hernia repair surgery. How do I know if I have one of these recalled mesh patches?

                      Depo-Testosterone Lawsuit TRT Lawsuits ww.depotestosteronelawsuit.com Depo-Testosterone Lawsuits are being filed in record numbers as thousands of men around the country report injuries after undergoing treatment.
                      osteoporosis in men – Fosamax Femur Fracture Lawsuits http://www.fosamaxlawsuitscenter.com Men taking Fosamax could also be at risk for injuries worse than their Osteoporosis, however, Fosamax studies have not focused on men.
                      Enzyte Scam Exposed! The Shocking Truth of Male Enhancement – http://www.enzytescam.com/

                      Kugel Hernia Mesh Patch Dangers – The Composix Kugel Mesh Patch is manufactured by Davol, Inc. (parent company: C.R. Bard, Inc.) and used in hernia surgery repair. Problems with the “memory recoil ring” that opens the Composix Kugel Mesh Patch can break under the stress of placement of the large sized products in the intra-abdominal space. This can lead to bowel perforations and/or chronic intestinal fistulae, or abnormal connections or passageways between the intestines and other organs. http://www.herniameshlawsuit.com/ – Hernia Mesh Recall Lawsuit Davol Bard Kugel Patch Lawyer

                      Testosterone Lawsuit Filings Continue, as New Study Questions Accuracy of Blood Tests Used to Diagnose Hypogonadism in Men – NEW YORK, March 14, 2014 /PRNewswire/ — As testosterone lawsuit (http://www.testosteronelawsuitcenter.com/) filings continue to mount against the manufacturers of AndroGel and similar medications, Bernstein Liebhard LLP notes that a new study is raising questions about the accuracy of blood tests used to diagnose hypogonadism (low testosterone) in men.

                      Testosterone therapies are approved to treat hypogonadism in men who suffer from the condition due to an underlying illness or injury. Drugs in this class include: Axiron- AndroDerm – AndroGel- Bio- T Gel- Delatestryl – Depo-Testosterone – Foresta – Striant – Testopel -Testim – The U.S. Food & Drug Administration (FDA) announced on January 31, 2014 that it had launched a safety review of prescription testosterone treatments after two studies indicated the medications might be associated with an increased risk of heart attack, stroke, and death in certain men. http://www.prnewswire.com/news-releases/testosterone-lawsuit-filings-continue-as-new-study-questions-accuracy-of-blood-tests-used-to-diagnose-hypogonadism-in-men-250351241.html

                      Axiron- AndroDerm – AndroGel- Bio- T Gel- Delatestryl – Depo-Testosterone – Foresta – Striant – Testopel -Testim

                      http://www.fda.gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ucm384225.htm” U.S. The Food & Drug Administration (FDA) Arial, announced on January 31, 2014 that it had launched a safety review of prescription testosterone treatments after two studies indicated the medications might be associated with an increased risk of heart attack, stroke, and death in certain men.

                      http://www.prnewswire.com/news-releases/testosterone-lawsuit-filings-continue-as-new-study-questions-accuracy-of-blood-tests-used-to-diagnose-hypogonadism-in-men-250351241.html

                      Additional information you may find interesting –

                      Schering AG struggled to rebuild its business during the difficult conditions that prevailed following the war. The company used its expertise in steroids to produce the first birth control pill, simply known as “the Pill,” introduced to the European market in 1961. With the profits from this product, Schering was able to diversify and one again try the U.S. market. In 1972 it acquired a half-interest in New Jersey-based Knoll Pharmaceutical, the first of several acquisitions Schering would make in the United States over the next several years.

                      http://articles.chicagotribune.com/2013-04-16/lifestyle/sns-rt-us-bayer-yasmin-patentbre93f13y-20130416_1_yaz-lupin-ltd-yasmin”

                      Baby Boom Forces Brazil To Confront Fake Medicines
                      By David Willman, Tribune Newspapers: Los Angeles Times.

                      http://www.bizjournals.com/eastbay/stories/2007/09/17/story15.html?
                      Bayer is locking in production and royalties from

                      http://www.bizjournals.com/profiles/company/ch/basel/novartis_ag/3010243”
                      Novartis AG which is selling the former Chiron facility and launching its own version of the drug. The deal, with points still being negotiated, allows Bayer’s Berkeley biotech subsidiary, Bayer HealthCare Pharmaceuticals, to add 550 people, and gives Bayer greater control over its Betaseron business, which had second-quarter sales of $353.7 million.

                      “This is a different environment, but it’s still an exciting opportunity,” said Alfred Merz, who heads Bayer’s Emeryville transition team. “It’s really forward-looking.”As Novartis brings its version of Betaseron to the market in 2009, Bayer will produce it, shed the royalties it currently makes to Novartis, and, instead, receive royalties from the Swiss drug giant. Bayer, says Michael Schuppenhauer, a biotech consultant in Half Moon Bay, must prove it has the attention span to build a strong biotech business. Bayer doesn’t appear to know its long-term strategy, he said. “Bayer has a lot of strategic decisions to make and a lot to do in their pipeline to be a serious, good biotech player,” he said.

                      Meanwhile, Novartis is expected eventually to market an oral multiple sclerosis drug that could be made elsewhere, whittle Bayer’s MS drug market share and Bayer’s Betaseron royalty receipts. Plus, other companies – including Alameda’s Pepgen Corp. and Palo Alto’s Bayhill Therapeutics Inc., both of which have products in Phase 2 clinical testing – are working on new-generation drugs for an MS market valued by drug-development companies at more than $5 billion. At the same time, Bayer is digesting last year’s acquisition of Schering AG, and rumors have surfaced that Novartis is targeting Bayer as a merger target.Leading Causes of Death by Age Group, Race/Ethnicity Males, United States, 2010* – http://www.cdc.gov/men/lcod/2010/LCODrace_ethnicityMen2010.pdf

                      Doctors of Death: Understanding THE HIPPOCRATIC OATH by – http://www.youtube.com/watch?v=B7ehZVZUXbs

                      Please Read Men of America
                      http://www.worldlifeexpectancy.com/usa/african-american-death-rate
                      African Death Rate Per 100,000 … CDC official final death report

                      Death by Medicine Trailer

                      Potential Testosterone Treatment Lawsuits Being Evaluated by Sim –

                      Men

                      TOP PRODUCERS IN AMERICA –
                      Medicine Or Mass Murder? Guideline Based on Discredited Research May Have Caused 800,000 Deaths In Europe Over The Last 5 Years
                      http://www.forbes.com/sites/larryhusten/2014/01/15/medicine-or-mass-murder-guideline-based-on-discredited-research-may-have-caused-800000-deaths-in-europe-over-the-last-5-years

                      Special Report: Hangar 1 The UFO Files E02 Underground Bases – http://www.youtube.com/watch?v=5iMJXnoQrO8

                      CABIRI,
                      Web Content Freelance Writer

                      Social Media – Venture Capital Pryamid Schemes

                      America look at this one! The company mentioned in the below blog; who is a partners with these companies – http://www.bigclassaction.com/lawsuit/geron-corporation-gern-securities-2.php – Geron Corporation GERN Securities Lawsuit
                      See the International pyramid scheme unfold in front of your eyes!

                      Consumer Advocacy Business Industry Research & Investigations (CABIRI)

                      SOCIAL MEDIA – VENTURE CAPITALIST – MEGA MERGERS – PHARMACEUTICAL – PRYAMID SCHEMES

                      Are there any more American Only based businesses in America, without a international country attached to it! Being a business owner you are sent many business opportunities, how in the world do you know if your being scammed or not? If your smart and research the company, you can find the true owners of the business with the main address location being in another country. How do you know who your truly doing business with if the company is also based in foreign country, with a subsidiary based in the United States. International laws and U.S. laws are totally different, along with you have know idea who is on the other end of the business.

                      The point, here is to make sure you do your homework before doing business with any company in the United States! To gain…

                      View original post 1,277 more words

                      Social Media – Venture Capital Pryamid Schemes

                      SOCIAL MEDIA – VENTURE CAPITALIST – MEGA MERGERS – PHARMACEUTICAL – PRYAMID SCHEMES

                      Are there any more American Only based businesses in America, without a international country attached to it! Being a business owner you are sent many business opportunities, how in the world do you know if your being scammed or not? If your smart and research the company, you can find the true owners of the business with the main address location being in another country. How do you know who your truly doing business with if the company is also based in foreign country, with a subsidiary based in the United States. International laws and U.S. laws are totally different, along with you have know idea who is on the other end of the business.

                      The point, here is to make sure you do your homework before doing business with any company in the United States! To gain back control of the United States, the American citizens must try and only do business with U.S. based businesses and American business owners! This way the revenue generated with these American based business will only go to stimulating the American Economy for the American people. Most importantly, to assist the many American families in need of help!

                      America please think about, how this can help our country to regain back, the many businesses that have been stripped away from America by international countries,forcing American citizen tax payers to fund many other countries instead of their own homeland country United States of America! Also, please see “Eugenics Theory” and “Population Council” you will view the hidden agenda’s behind all of the series of events occurring in America. 

                      View below US based – International based Companies: 

                      Company Address: Empower Network, LLC 146 Second Street North St. Petersburg, Florida 33701 Suite
                      UK Address (Correspondence Not Accepted):
                      Empower Network Limited 66-68 High Road Bushey Heath, Herts WD23 1GG 

                      http://www.avoidonlinemoneyscams.com/2013/03/jeffbuchananinstantpaydaynetwork.html

                      Instant Payday Network by Jeff Buchanan Review – is it a SCAM or legit?

                      See questionable information about the site which somehow links to the
                      company above, granted both of these businesses are advertising via email,
                      craigslist and Google.

                      Please be aware America! (Below information included in above link)!

                      I have two major problems with the system. When you reach step 4 it is obvious that Instant Payday Network is essentially a carrot and it is being used as a means of converting you into a Empower Network sale, this has not been made very clear and it is a bit sneaky. I am not in anyway calling empower network a bad thing and will be doing my own review on this.

                      Instant Payday Network by Jeff Buchanan

                      The next major problem I have is I wonder about the validity of Jeff as an entity when I look at the pages of this system. I look at the bottom of each of the pages and I see Satori Primes logo so this immediately makes me think hmmmmm. This was backed up particularly when I started receiving emails from Guy Ferdman when it was Jeff’S referral ID I signed up with.

                      In researching you’ll find Mr. Guy Ferdman at the following links, which are also questionable?
                      http://satoriprimeacademy.com/business-opportunities/
                      http://www.coolsocial.net/sites/www/satoriprimeacademy.com.html

                      http://www.coolsocial.net/keyword-analyzer.aspx?url=http://www.satoriprimeacademy.com
                      You’ll view here the statistical rating of the business which is contradictory to what being marketed as being a lead producer world-wide?

                      Additional research on the server information of Satori per below website: CloudFare Internationally connected although businesses based online with a office location in California
                      http://www.ranklite.se/www/satoriprime.com

                      CloudFlare received media attention in June 2011, not all of it positive, after providing security to LulzSec website

                      http://en.wikipedia.org/wiki/CloudFlare
                      In July 2011, CloudFlare announced receiving $20 million in venture funding from New Enterprise Associates, Venrock, and Pelion Venture Partners, after receiving $2 million in earlier funding. It had raised the additional funding in November 2010.

                      In October 2011, CloudFlare was named as the Most Innovative Network & Internet Technology Company of 2011 by Wall Street Journal. The World Economic Forum (WEF) noted CloudFlare innovative algorithms and ability to adapt in its Technology Pioneers 2012 report. The WEF called LulzSec use of CloudFlare services a vote of confidence in CloudFlare approach.

                      In June 2012, the hacker group UGNazi attacked CloudFlare partially via flaws in Google authentication systems, gaining administrative access to CloudFlare and using it to deface 4chan.

                      Additional Private Venture Fund office –
                      New Enterprise Assoc. – Beijing, Shanghai, Mumbai
                      NEA invests in three broad industry sectors: information technology, health care, and energy technology, with investment professionals allocated to each industry! Very Interesting??

                      Please review this article about NEA who tied to Clinical Trials and Cancer in America & Social Media! WOW!
                      Venture Capitalist Dick Kramlich Last Stand
                      http://www.businessweek.com/magazine/content/10_05/b4165061411746.htm
                      http://www.projecthoneypot.org/ – Email snooping tied to law enforcement per the website

                      The 2nd donor Venrock is a nightmare also tied to Big Pharma CANCER & the Rockefellers who are the patent owners of the Mirena – IUD! See Below link for additional information!

                      Venrock, a compound of and Rockefeller, is a pioneering venture capital firm formed in 1969 to build upon the successful investing activities of the Rockefeller family that began in the late 1930s. It has offices in Palo Alto, California, New York City, Cambridge, Massachusetts, and Israel!

                      Also view this company tied to Venrock – Genron – Geron Corporation is a biotechnology company located in Menlo Park, California that specializes in developing and commercialization of products in three specific areas: 1) therapeutic products for cancer that inhibit telomerase; 2) pharmaceuticals that activate telomerase in tissues impacted by cell aging, injury or degenerative diseases; and 3) cell-based therapies derived from human embryonic stem cells for treatment of various chronic diseases – http://en.wikipedia.org/wiki/Geron_Corporation

                      More History on Venrock: In the healthcare sector, Venrock has invested in HealthSouth Corporation, MedPartners, Inc. Caliper Technologies Corporation, Centocor, Geron,[1] Genetics Institute, Idec Pharmaceuticals Corporation, Illumina, Millennium Pharmaceuticals, Sirna Therapeutics, athenahealth and Sugen.

                      In 1999, Venrock and Kleiner Perkins Caufield & Byers, in coordination with Michael D. West, now CEO of BioTime, invested in West's Geron Corporation (NASDAQ: GERN). Venrock General Partner Patrick Latterell served on the company Board of Directors and the company went on to initiate the first embryonic stem cell-based clinical trial.

                      On July 19, 2013 it was announced that Daniel Loreto, engineering lead for Twitter and Google is joining Venrock as EIR – The EIR role in a venture capital firm is often designed to fill one of three primary functions; To launch a new entrepreneurial venture, often with the backing of the parent firm or organization; To assist in the evaluation of potential investments where the entrepreneur has a particular expertise; To provide functional expertise to assist with an existing investment

                      The more you research the worse it get's – They are also linked to criminal hackers – via CIA, Sony, Fox.com, see more information: http://en.wikipedia.org/wiki/LulzSec

                      Just think this was all based upon researching 2 emails sent to get you to sign up for their
                      programs. This is to get all your information, they are using PayPal as their base payment
                      hub see: From July 2007, PayPal has operated across the European Union as a Luxembourg-based bank.
                      http://en.wikipedia.org/wiki/Paypal

                      As you viewed this could be the working of a pyramid marketing scheme by all these businesses on
                      many levels! Which all ties back to international, European control and the Rockefellers in the
                      pharmaceutical cancer area! Is this why their has been an influx in Cancer in America, which
                      is again America a population control tactic via Eugenics Theory!

                      Here is the definition of a pyramid scheme via SEC website;
                      http://www.sec.gov/answers/pyramid.htm
                      Pyramid Schemes

                      In the classiC scheme, participants attempt to make money solely by recruiting new participants into the program. The hallmark of these schemes is the promise of sky-high returns in a short period of time for doing nothing other than handing over your money and getting others to do the same.

                      The fraudsters behind a pyramid scheme may go to great lengths to make the program look like a legitimate multi-level marketing program. But despite their claims to have legitimate products or services to sell, these fraudsters simply use money coming in from new recruits to pay off early stage investors. But eventually the pyramid will collapse. At some point the schemes get too big, the promoter cannot raise enough money from new investors to pay earlier investors, and many people lose their money. The chart below shows how pyramid schemes can become impossible to sustain:

                      View this link again to see the connection between pyramid schemes:
                      Venture Capitalist Dick Kramlich Last Stand
                      http://www.businessweek.com/magazine/content/10_05/b4165061411746.htm

                      CABIRI,
                      Web Content Research Freelance Writer